Stephen A. Gorgol

BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA.

Part of uniQure NV, uniQure, Inc. provides research and development services of human gene based therapies. The company is based in Lexington, MA.

BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA.

iVOW Inc, formerly Vista Medical Technologies, Inc. (VMTI) is a disease state management company focused on the treatment of morbid obesity. The company operates two business units: Obesity Surgical and Medical Management Services and Visualization Technology. The Obesity Surgical and Medical Management Services business, operated by the Company's wholly owned subsidiary, VOW Solutions, Inc., provides services to physicians and hospitals involved in the surgical treatment of morbid obesity. Its services include management of the Company's original product offering, the Laparoscopic Bariatric Surgery Preceptorship, an introduction to starting a minimally invasive gastric bypass surgical program. In addition, the business offers consulting and program management services, which enable the efficient operation of obesity surgery programs.

BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom.